On 15 March, the US FDA, the US food and drug regulatory agency under the Department of Health, published a new white paper entitled ‘Artificial Intelligence and Medical Products: How CBER, CDER…

AI in Plain English

The US FDA has published a white paper on AI and Medical Products, outlining areas of interest in the development of AI in the medical field. The paper focuses on promoting collaboration to safeguard public health, developing regulatory approaches to support innovation, establishing standards and guidelines for the life cycle of medical products, and supporting research on evaluating and monitoring the performance of artificial intelligence.

White Paper on AI and Medical Products by the US FDA